IDEXX Laboratories Inc. (IDXX): Price and Financial Metrics
IDXX Price/Volume Stats
Current price | $539.93 | 52-week high | $583.39 |
Prev. close | $539.57 | 52-week low | $372.50 |
Day low | $537.39 | Volume | 290,100 |
Day high | $543.33 | Avg. volume | 428,298 |
50-day MA | $547.93 | Dividend yield | N/A |
200-day MA | $503.15 | Market Cap | 44.86B |
IDXX Stock Price Chart Interactive Chart >
IDXX POWR Grades
- Quality is the dimension where IDXX ranks best; there it ranks ahead of 93.96% of US stocks.
- IDXX's strongest trending metric is Growth; it's been moving down over the last 26 weeks.
- IDXX ranks lowest in Momentum; there it ranks in the 27th percentile.
IDXX Stock Summary
- IDEXX LABORATORIES INC's market capitalization of $44,437,643,672 is ahead of 94.27% of US-listed equities.
- The price/operating cash flow metric for IDEXX LABORATORIES INC is higher than 93.8% of stocks in our set with a positive cash flow.
- IDXX's price/sales ratio is 12.39; that's higher than the P/S ratio of 91.13% of US stocks.
- If you're looking for stocks that are quantitatively similar to IDEXX LABORATORIES INC, a group of peers worth examining would be CARR, FTV, CSGP, XYL, and ALGN.
- IDXX's SEC filings can be seen here. And to visit IDEXX LABORATORIES INC's official web site, go to www.idexx.com.
IDXX Valuation Summary
- In comparison to the median Healthcare stock, IDXX's price/earnings ratio is 92.11% higher, now standing at 56.
- IDXX's EV/EBIT ratio has moved up 26.6 over the prior 243 months.
Below are key valuation metrics over time for IDXX.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
IDXX | 2023-12-29 | 12.8 | 35.5 | 56.0 | 43.4 |
IDXX | 2023-12-28 | 12.9 | 35.7 | 56.2 | 43.5 |
IDXX | 2023-12-27 | 12.9 | 35.7 | 56.2 | 43.5 |
IDXX | 2023-12-26 | 12.9 | 35.6 | 56.1 | 43.5 |
IDXX | 2023-12-22 | 12.8 | 35.5 | 55.9 | 43.3 |
IDXX | 2023-12-21 | 12.8 | 35.4 | 55.8 | 43.2 |
IDXX Growth Metrics
- Its 5 year price growth rate is now at 65.5%.
- Its 2 year net cashflow from operations growth rate is now at 64.77%.
- Its year over year revenue growth rate is now at 14.56%.
The table below shows IDXX's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 3,367.324 | 542.984 | 679.089 |
2022-09-30 | 3,339.846 | 579.52 | 669.653 |
2022-06-30 | 3,308.606 | 577.725 | 663.95 |
2022-03-31 | 3,274.202 | 745.83 | 734.553 |
2021-12-31 | 3,215.36 | 755.546 | 744.845 |
2021-09-30 | 3,135.208 | 764.516 | 756.864 |
IDXX's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- IDXX has a Quality Grade of A, ranking ahead of 96.19% of graded US stocks.
- IDXX's asset turnover comes in at 1.342 -- ranking 14th of 680 Pharmaceutical Products stocks.
- IMGN, RMTI, and MTEX are the stocks whose asset turnover ratios are most correlated with IDXX.
The table below shows IDXX's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 1.342 | 0.588 | 0.424 |
2021-03-31 | 1.325 | 0.589 | 0.389 |
2020-12-31 | 1.322 | 0.580 | 0.344 |
2020-09-30 | 1.341 | 0.576 | 0.319 |
2020-06-30 | 1.332 | 0.572 | 0.314 |
2020-03-31 | 1.366 | 0.567 | 0.313 |
IDXX Price Target
For more insight on analysts targets of IDXX, see our IDXX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $717.50 | Average Broker Recommendation | 1.56 (Moderate Buy) |
IDEXX Laboratories Inc. (IDXX) Company Bio
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 and headquartered in Westbrook, Maine, and EMEA in Hoofddorp, Netherlands, IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions (as of 7 February 2020). There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy (LPD). In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. (Source:Wikipedia)
Latest IDXX News From Around the Web
Below are the latest news stories about IDEXX LABORATORIES INC that investors may wish to consider to help them evaluate IDXX as an investment opportunity.
Here's Why You Should Invest in IDEXX (IDXX) Stock Right NowInvestors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business. |
Should You Add IDEXX Laboratories (IDXX) to Your Portfolio?TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the strategy outperformed the Russell Midcap Growth Index and returned -4.11% (net) while the index return was -5.22%. The third quarter saw a decline in […] |
Insider Sell: Executive Vice President James Polewaczyk Sells Shares of IDEXX Laboratories IncIn a notable insider transaction, Executive Vice President James Polewaczyk has parted with 11,636 shares of IDEXX Laboratories Inc (NASDAQ:IDXX), a leader in veterinary diagnostics, software, and water microbiology testing. |
Insider Sell: President and CEO Jonathan Mazelsky Sells Shares of IDEXX Laboratories Inc (IDXX)In a notable insider transaction, President and CEO Jonathan Mazelsky has parted with 7,128 shares of IDEXX Laboratories Inc (NASDAQ:IDXX), a leader in veterinary diagnostics, veterinary practice software, and water microbiology testing. |
IDEXX Laboratories Schedules Two Institutional Investor EventsWESTBROOK, Maine, December 07, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming institutional investor events: |
IDXX Price Returns
1-mo | -5.55% |
3-mo | -2.72% |
6-mo | 23.48% |
1-year | 9.40% |
3-year | 13.44% |
5-year | 141.47% |
YTD | -2.72% |
2023 | 36.06% |
2022 | -38.04% |
2021 | 31.73% |
2020 | 91.43% |
2019 | 40.38% |
Continue Researching IDXX
Here are a few links from around the web to help you further your research on Idexx Laboratories Inc's stock as an investment opportunity:Idexx Laboratories Inc (IDXX) Stock Price | Nasdaq
Idexx Laboratories Inc (IDXX) Stock Quote, History and News - Yahoo Finance
Idexx Laboratories Inc (IDXX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...